| Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota M Vétizou, JM Pitt, R Daillère, P Lepage, N Waldschmitt, C Flament, ... Science 350 (6264), 1079-1084, 2015 | 2681 | 2015 |
| The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide S Viaud, F Saccheri, G Mignot, T Yamazaki, R Daillère, D Hannani, ... science 342 (6161), 971-976, 2013 | 1736 | 2013 |
| Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy A Sistigu, T Yamazaki, E Vacchelli, K Chaba, DP Enot, J Adam, I Vitale, ... Nature medicine 20 (11), 1301-1309, 2014 | 898 | 2014 |
| Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and-extrinsic factors JM Pitt, M Vétizou, R Daillère, MP Roberti, T Yamazaki, B Routy, ... Immunity 44 (6), 1255-1269, 2016 | 815 | 2016 |
| Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy C Pfirschke, C Engblom, S Rickelt, V Cortez-Retamozo, C Garris, F Pucci, ... Immunity 44 (2), 343-354, 2016 | 790 | 2016 |
| Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells Y Ma, S Adjemian, SR Mattarollo, T Yamazaki, L Aymeric, H Yang, ... Immunity 38 (4), 729-741, 2013 | 630 | 2013 |
| Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects R Daillère, M Vétizou, N Waldschmitt, T Yamazaki, C Isnard, ... Immunity 45 (4), 931-943, 2016 | 626 | 2016 |
| Consensus guidelines for the definition, detection and interpretation of immunogenic cell death L Galluzzi, I Vitale, S Warren, S Adjemian, P Agostinis, AB Martinez, ... Journal for immunotherapy of cancer 8 (1), 2020 | 563 | 2020 |
| Caloric restriction mimetics enhance anticancer immunosurveillance F Pietrocola, J Pol, E Vacchelli, S Rao, DP Enot, EE Baracco, S Levesque, ... Cancer cell 30 (1), 147-160, 2016 | 441 | 2016 |
| An immunosurveillance mechanism controls cancer cell ploidy L Senovilla, I Vitale, I Martins, M Tailler, C Pailleret, M Michaud, L Galluzzi, ... Science 337 (6102), 1678-1684, 2012 | 397 | 2012 |
| Cardiac glycosides exert anticancer effects by inducing immunogenic cell death L Menger, E Vacchelli, S Adjemian, I Martins, Y Ma, S Shen, T Yamazaki, ... Science translational medicine 4 (143), 143ra99-143ra99, 2012 | 387 | 2012 |
| Detection of immunogenic cell death and its relevance for cancer therapy J Fucikova, O Kepp, L Kasikova, G Petroni, T Yamazaki, P Liu, L Zhao, ... Cell death & disease 11 (11), 1013, 2020 | 324 | 2020 |
| Linking cellular stress responses to systemic homeostasis L Galluzzi, T Yamazaki, G Kroemer Nature Reviews Molecular Cell Biology 19 (11), 731-745, 2018 | 306 | 2018 |
| Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists T Yamazaki, D Hannani, V Poirier-Colame, S Ladoire, C Locher, A Sistigu, ... Cell Death & Differentiation 21 (1), 69-78, 2014 | 211 | 2014 |
| A threshold level of intratumor CD8+ T-cell PD1 expression dictates therapeutic response to anti-PD1T-cell PD1 levels set a threshold for response SF Ngiow, A Young, N Jacquelot, T Yamazaki, D Enot, L Zitvogel, ... Cancer research 75 (18), 3800-3811, 2015 | 208 | 2015 |
| Crizotinib-induced immunogenic cell death in non-small cell lung cancer P Liu, L Zhao, J Pol, S Levesque, A Petrazzuolo, C Pfirschke, C Engblom, ... Nature communications 10 (1), 1486, 2019 | 191 | 2019 |
| Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy T Yamazaki, A Kirchmair, AI Sato, A Buque, M Rybstein, G Petroni, N Bloy, ... Nature Immunology 21 (10), 1160-1171, 2020 | 176 | 2020 |
| Crosstalk between ER stress and immunogenic cell death O Kepp, L Menger, E Vacchelli, C Locher, S Adjemian, T Yamazaki, ... Cytokine & growth factor reviews 24 (4), 311-318, 2013 | 168 | 2013 |
| Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade N Jacquelot, T Yamazaki, MP Roberti, CPM Duong, MC Andrews, ... Cell research 29 (10), 846-861, 2019 | 153 | 2019 |
| Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy H Yang, Y Ma, G Chen, H Zhou, T Yamazaki, C Klein, F Pietrocola, ... Oncoimmunology 5 (6), e1149673, 2016 | 149 | 2016 |
